-
The Safety of 5-Chloro-6-isoquinolinamine
Time of Update: 2023-05-09
In addition to its potential cancer-causing effects, 5-Chloro-6-isoquinolinamine has also been linked to other health problems, including respiratory issues, skin irritation, and neurological effects.
In addition to its potential cancer-causing effects, 5-Chloro-6-isoquinolinamine has also been linked to other health problems, including respiratory issues, skin irritation, and neurological effects.
-
The Safety of 3,6-DIBROMO-9-PHENYLCARBAZOLE
Time of Update: 2023-05-09
DBPC has a wide range of applications, including as a catalyst for the polymerization of various monomers, as a flame retardant in plastics, and as a research reagent in organic synthesis.
-
The Safety of 6-Methyl-5-nitroquinoline
Time of Update: 2023-05-07
In addition to its potential carcinogenic and genotoxic effects, 6-MNQ can also cause other health problems, including skin irritation, respiratory problems, and reproductive toxicity.
In addition to its potential carcinogenic and genotoxic effects, 6-MNQ can also cause other health problems, including skin irritation, respiratory problems, and reproductive toxicity.
-
The Safety of 2-Pyridinecarboxylic acid, 6-methyl-, methyl ester
Time of Update: 2023-05-04
One of the main concerns when it comes to the safety of 2-Pyridinecarboxylic acid, 6-methyl-, methyl ester is its potential to cause skin irritation.
One of the main concerns when it comes to the safety of 2-Pyridinecarboxylic acid, 6-methyl-, methyl ester is its potential to cause skin irritation.
-
Indian government to restrict the use of glyphosate All registration certificates will be returned to the Registration Board
Time of Update: 2022-11-04
"World Agrochemical Network Chinese Network reported: Recently, the Indian government said that due to concerns about the harm to human and animal health, it officially restricted the use of the widely used herbicide glyphosate.
-
42% lower risk of death! The team of Ye Dingwei of Fudan University released the first Chinese plan for the treatment of metastatic hormone-sensitive prostate cancer
Time of Update: 2022-09-21
On September 5, 2022, the team of Ye Dingwei of the Department of Urology of the Affiliated Cancer Hospital of Fudan University published a research paper in the journal Lancet Oncology, which lasted more than 4 years, comparing the efficacy and safety of "revirutrum combined castration therapy" and the classic "bicalutamide combined castration therapy" in patients with high tumor load metastatic hormone-sensitive prostate cancer, confirming the first new second-generation anti-male drug "revirutamine" independently developed by China.
-
High levels of DHA in blood can reduce Alzheimer's risk by 50
Time of Update: 2022-09-03
Red Blood Cell DHA Is Inversely Associated with Risk of Incident Alzheimer's Disease and All-Cause Dementia: Framingham Offspring Study)", this prospective study was jointly conducted by scholars from the American Fatty Acid Institute, Boston University, University of South Dakota and other institutions .
-
Baricitinib: 80% hair regrowth in 40% of alopecia areata patients NEJM Review
Time of Update: 2022-08-15
The results showed that at week 36, baricitinib 4 The proportion of patients with 80% or more scalp hair coverage in the mg group was close to 40%, and the proportion of complete or almost complete regrowth of eyebrows and eyelashes was also close to 40% On May 5, 2022, the New England Journal of Medicine (NEJM) published two Phase 3 trials, BRAVE-AA1 and BRAVE-AA2, of oral baricitinib in the treatment of alopecia areata.
-
Nat Commun: Scientists discover potential therapeutic target for pancreatic cancer
Time of Update: 2022-05-20
immunityRecently, an academic paper titled "USP25 promotes pathological HIF-1-driven metabolic reprogramming and is a potential therapeutic target in pancreatic cancer" published in Nature Communications found that USP25 acts as a basic DUB required for PDAC tumor growth and viability.
-
Nat Commun Zhu Ping's team found that TNF antagonists combined with ferroptosis inducers alleviate the progression of rheumatoid arthritis
Time of Update: 2022-05-02
Recently, the team of Professor Zhu Ping, Department of Clinical Immunology, Xijing Hospital, Air Force Military Medical University published a research work entitled TNF antagonist sensitizes synovial fibroblasts to ferroptotic cell death in collagen-induced arthritis mouse models in the journal Nature Communications, and found that in the progression of rheumatoid arthritis , tumor necrosis factor TNF is a key signal regulating the resistance to ferroptosis in synovial fibroblasts .
-
First CLL patient to receive CAR T-cell therapy reaches 10-year complete remission
Time of Update: 2022-04-30
Komaroff, MD Two Cases of Aggressive CLL Patients Long-term complete remission was achieved after receiving CAR T-cell therapy .
Comments CAR T-cell therapy has achieved complete remission at 10 years in at least two patients with aggressive CLL .
-
Seeing DWI High Signal: These 5 Diseases Can't Be Ignored
Time of Update: 2022-04-24
，DWI ，，、 DWI ，: （CJD, Creutzfeldt–Jakob disease）。， CJD，「」，， / DWI 。 Among a series of diseases in neurology, the most common DWI high signal is naturally ischemic stroke and acute phase stroke . I am
-
Zhang Feng's new paper: CRISPR activation screening to discover key proteins of cancer immunotherapy resistance
Time of Update: 2022-04-23
The study found that BCL-2 and B3GNT2 are key drivers of cancer cell resistance to cytotoxic T cells through CRISPRa Screen, and inhibition of these two proteins can enhance the sensitivity of tumor tissue to immunotherapyThis result suggests that a CRISPR-activated screening system can help to elucidate resistance pathways and identify potential targets for cancer immunotherapy .
-
[Science Sub-Journal] A cheap oral drug-arginine, can enhance the effect of cancer radiotherapy
Time of Update: 2021-11-14
Roffo Cancer Institute showed that treatment with arginine (an amino acid building block of protein) can enhance patients with cancer brain metastases The effectiveness of radiotherapy .
-
ANN NEUROL: Cancer patients have higher blood coagulation markers and are susceptible to ischemic stroke
Time of Update: 2021-11-12
The study found that compared with the control group, patients with active cancer and acute ischemic stroke had higher coagulation, platelet and endothelial cell activation markers, and more circulating microemboli .
